Pharmaceutical major, Lupin Ltd on 18 September announced that they have signed a non-exclusive patent licensing arrangement to bring the novel gastrointestinal medication Vonoprazan tablets...
Shares of Lupin Ltd. were trading in the green and 1.8% higher on 21 June after the company’s manufacturing facility in Somerset, New Jersey, received...
Pharmaceutical major Lupin announced on Wednesday, June 5, that its European subsidiary has completed the acquisition of two brands from Sanofi. In its regulatory filing,...